Immunoglobulins: Global Market Scenario, Trends, Opportunity, Growth and Forecast, 2018-2028

Market Definition

White blood cells create the glycoproteins known as antibodies and immunoglobulins.  As they recognise and attach to antigens like bacteria, viruses, and cancer cells, they are essential to the immune response. When the body has a tuberculosis infection, the immune system produces antibodies that only attach to the tuberculosis germs. This is an example of how immunoglobulins have a specific mode of action. Immunoglobulins bind to various cell types via receptors on each cell, including phagocytic cells, platelets, mast cells, lymphocytes, and basophils. The binding makes it easier for these cells to activate and enables them to perform their unique tasks.

Market Insights

In 2020, it was predicted that the global immunoglobulins (IG) market would be worth $16.23 billion. By the end of 2028, the immunoglobulins market is anticipated to develop at a compound annual growth rate (CAGR) of 5.8% and cross $20 billion mark. The present immunoglobulins market is expanding as a result of rising blood donations and rising demand for immunoglobulins in various therapies. The development of the market may be hampered by rising research into alternative medicines and expensive manufacturing and healthcare costs related to immunoglobulin products. Increasing investments in plasma fractionation capabilities and expanding research on new formulations and indications should generate a tonne of potential for market suppliers in addition to drivers and limitations.

Currently, the market for immunoglobulins worldwide is dominated by the North American continent. The share generated by this region in 2020 was around 42% of the global market. The availability of sizable fractionation facilities and the rising need for immunoglobulins to treat various immunodeficiency illnesses are key growth drivers in this region. In 2020, the market for immunoglobulins in Asia-Pacific was worth more than $2.3 billion. The market in this area is being driven primarily by the expansion of domestic plasma fractionation businesses in nations like South Korea and India.

The immunoglobulins market has been divided into intravenous (IV), subcutaneous (SC), and other segments based on the method of administration. The SC section is anticipated to experience the highest CAGR of any route segment during the forecast period, at 13%.

Market Dynamics: Drivers

Increasing Demand for Immunoglobulins in Therapeutic Treatments

Blood plasma is the source of the sterile, refined compounds known as immunoglobulins. The blood plasma market is expanding as a result of immunoglobulin-based therapies being widely accepted and rising subcutaneous immunoglobulin demand. Immunoglobulins are being used more often in a number of therapeutic fields, including cardiology, rheumatology, dermatology, nephrology, and infectious disorders. Immunoglobulins have become more frequently used in blood plasma therapy recently as a result of their promise for treating conditions like:

• PID
• ITP
• Lymphocytic lymphoma
• Kawasaki disease
• HIV/AIDS
• Guillain-Barré syndrome
• CIPD

Market Dynamics: Challenges

Increasing Research on Alternative Therapies

Utilizing cutting-edge techniques like recombinant products, monoclonal antibodies, and gene therapies is becoming more popular. The conventional way of treatment involves isolating immunoglobulins from pooled human blood. The multiple hazards connected with blood plasma therapy, such as epidemics brought on by the spread of blood-borne viruses including hepatitis B, hepatitis C, and human immunodeficiency virus (HIV), are a factor in the interest in alternative treatment options. The creation of the recombinant technology resulted from the need for a safer strategy due to the risk of spreading blood-borne diseases.

Market Segmentation

• Based on Type, the Global Immunoglobulins market is segmented into
  • Normal Immunoglobulin
  • Hyperimmune Globulins
• Based on Route of Administration, the Global Immunoglobulins market is segmented into
  • Intravenous (IV)
  • Subcutaneous (SC)
  • Others
• Based on Application, the Global Immunoglobulins market is segmented into
  • Primary Immune Deficiency (PID)
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Secondary Immune Deficiency (SID)
  • Multifocal Motor Neuropathy (MMN)
  • Other Neurological Disorders
  • Others
• Based on Region, the Global Immunoglobulins market is segmented into
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

• All market revenue has been given in US Dollar.

Historical Year: 2018-2019
Base Year: 2020
Estimated: 2021
Forecast- 2022-2028

Key Questions this Study will Answer

• What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Market Size-By Volume, Forecast Numbers, Market Segmentation, Market Shares) of Global Immunoglobulins Market?
• What is the region wise industry size, growth drivers and challenges key market trends?
• What are the key innovations, opportunities, current and future trends and regulations in the Global Immunoglobulins Market?
• Who are the key competitors, what are their key strength and weakness and how they perform in Global Immunoglobulins Market based on competitive benchmarking matrix?
• What are the key results derived from the market surveys conducted during Global Immunoglobulins Market study?